Tuesday, April 23, 2013
Pharmaceutical business: new borders for the application of abuse of dominant position
The Court of Justice of the European Union held, for the first time, that a claim based on abuse of dominant position can be enforced within the pharmaceutical sector. Indeed, the pharmaceutical market was previously exempt from enforcement of this kind of claim in order to promote research and innovation. We publish the article written by Luca Ghedina and Lorenzo Gyulai published on the English web-based legal forum "Lexology":
Previous Article The bank account freeze: a forceful measure to safeguard the industrial and intellectual property
Next Article Bad faith in philanthropy and trademark registrations: what goes around, comes around